Published in

American Society of Hematology, Blood, 1(128), p. e1-e9, 2016

DOI: 10.1182/blood-2015-11-683334

Links

Tools

Export citation

Search in Google Scholar

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Key Points We develop and validate Karyogene, a comprehensive one-stop diagnostic platform for the genomic analysis of myeloid malignancies. Karyogene simultaneously detects substitutions, insertions/deletions, translocations, copy number and zygosity changes in a single assay.